Hitoshi Tsuda - Nanotechnology

Author Information

Dr. Hitoshi Tsuda is a distinguished researcher currently affiliated with the Department of Basic Pathology at the National Defense Medical College in Tokorozawa, Saitama, Japan. His research spans various aspects of pathology with a particular focus on cancer studies. With a robust career in medical research, Dr. Tsuda has significantly contributed to the understanding and treatment of numerous types of cancer.

Research Contributions

In 2022 alone, Dr. Hitoshi Tsuda authored several impactful papers, addressing a range of topics from gastric cancer to ovarian carcinoma and breast cancer. Key studies include the overexpression of Tetraspanin31 in gastric cancer, the development of intraoperative methods for breast cancer margin assessment, and the clinical significance of CD8-positive lymphocytes in ovarian carcinoma. His work also extends to the validation of nuclear grading systems for invasive breast carcinoma and the prediction of early systemic recurrence in breast cancer, showcasing his dedication to improving diagnostic and therapeutic strategies in oncology.

Aliases

Dr. Hitoshi Tsuda is also known by several aliases in scholarly databases: H Tsuda, H. Tsuda, and Hitoshi Tsuda.

Publication and Citation Metrics

Metric	Value
Citation Count	24,645
h-index	80
Paper Count	705

Publications:

Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer.

DOI: 10.1111/cas.15342

Year: 2022

Development of An Intraoperative Breast Cancer Margin Assessment Method Using Quantitative Fluorescence Measurements

DOI: 10.21203/rs.3.rs-1230135/v1

Year: 2022

Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis

DOI: 10.1186/s13000-022-01195-7

Year: 2022

Clinical significance of CD8-positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high-grade serous carcinoma.

DOI: 10.1002/cam4.4592

Year: 2022

Magnetic resonance imaging findings of pure prostatic ductal adenocarcinomas: a case series

DOI: 10.1007/s00261-022-03454-z

Year: 2022

Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages

DOI: 10.1186/s12885-022-09363-0

Year: 2022

Abstract P1-02-09: Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (ILC)

DOI: 10.1158/1538-7445.sabcs21-p1-02-09

Year: 2022

A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large‐scale, multicenter cohort study

DOI: 10.1002/cncr.34144

Year: 2022

Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese Clinical Oncology Group.

DOI: 10.1016/j.humpath.2022.03.007

Year: 2022

Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial

DOI: 10.1007/s12282-022-01350-4

Year: 2022

What is Attenuated Total Reflectance (ATR)?

How Can Material Degradation Be Mitigated?

How Does Topological Superconductivity Differ from Conventional Superconductivity?

Why are Metadata Standards Important?

Why are High Pressure Studies Important in Nanotechnology?

How to Optimize DLS Measurements?

What is Nanotechnology Waste?

What are the Environmental Impacts of Using Nanotechnology in Fishery?

Why is Cooling Important in Nanotechnology?

What are Domain Walls?

Partnered Content Networks

Relevant Topics